ResearcherMedical College of WisconsinActive in the last 2 years

Elizabeth Diane Auckley

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3267-0247; OpenAlex author ID A5018016983. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 1 paper

Papers 1

MEK inhibitor-based genomically matched combinatorial targeted therapies in metastatic pancreatic adenocarcinoma with KRAS alterations. Co-author DOI 10.1093/oncolo/oyag040 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sam Z. Thalji · 1 shared paper, 2026 · strength 0.27
- Paper MEK inhibitor-based genomically matched combinatorial targeted therapies in metastatic pancreatic adenocarcinoma with K… DOI 10.1093/oncolo/oyag040 ↗
Mohammed Aldakkak · 1 shared paper, 2026 · strength 0.27
- Paper MEK inhibitor-based genomically matched combinatorial targeted therapies in metastatic pancreatic adenocarcinoma with K… DOI 10.1093/oncolo/oyag040 ↗
Thomas B. McFall · 1 shared paper, 2026 · strength 0.27
- Paper MEK inhibitor-based genomically matched combinatorial targeted therapies in metastatic pancreatic adenocarcinoma with K… DOI 10.1093/oncolo/oyag040 ↗
Mandana Kamgar · 1 shared paper, 2026 · strength 0.27
- Paper MEK inhibitor-based genomically matched combinatorial targeted therapies in metastatic pancreatic adenocarcinoma with K… DOI 10.1093/oncolo/oyag040 ↗
Razelle Kurzrock MD · 1 shared paper, 2026 · strength 0.27
- Paper MEK inhibitor-based genomically matched combinatorial targeted therapies in metastatic pancreatic adenocarcinoma with K… DOI 10.1093/oncolo/oyag040 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.